Hydroxychloroquine plus prednisone for ANA-positive ITP
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study tests whether a combination of hydroxychloroquine (HCQ) and prednisone (a steroid) is safe and effective for treating immune thrombocytopenia (ITP) in people who have a positive ANA blood test. It may be an option for those with low platelets and bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 75, or between 15 and 75 with uncontrolled high blood pressure or diabetes.
- You have a platelet count below 30,000 (or below 50,000 with bleeding) in the last week.
- Your antinuclear antibody (ANA) test is positive, but other autoantibodies are negative.
- You have not had a blood clot, stroke, or heart attack recently.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have a serious infection like HIV, hepatitis B or C, or other major health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding hydroxychloroquine (HCQ) to the steroid dexamethasone (DEX) works better than dexamethasone alone for adults with immune thrombocytopenia (ITP) who have a positive antinuclear antibody (ANA) blood test. The goal is to see if this combination can safely raise platelet counts and reduce bleeding risk.
This trial tests if combining two medicines (HCQ and a TPO-RA) can help people with a type of low platelet count called ITP who also have a positive ANA blood test. The goal is to see if this combination works better than standard treatments.
This trial tests a new combination of two medicines—romiplostim N01 (a shot to raise platelets) and rituximab (an infusion that calms the immune system)—for people with primary immune thrombocytopenia (ITP) who have not had enough improvement from oral TPO-RA pills like hetrombopag or eltrombopag. It aims to see if this combination works better and is safe.
This study tests a combination of multiple drugs given in sequence to adults with newly diagnosed immune thrombocytopenia (ITP), a condition of low platelets. The goal is to see if this approach improves platelet counts and is safe.
This study tests a combination of three treatments—steroids, IVIG, and romiplostim (Nplate)—for adults with severe, newly diagnosed ITP that hasn't responded well to standard therapy. The goal is to see if this triple therapy can quickly raise platelet counts and stop bleeding.
This trial compares two treatments for pregnant women with ITP (immune thrombocytopenia) and low platelet counts. It tests whether adding IVIg (immune globulin) to standard prednisone (steroid) therapy is more effective than prednisone alone.
Hear when a new Immune Thrombocytopenia With Positive ANA Antibodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.